These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 11367171)
1. Activism today: the Coalition for Salvage Therapy. Interview with Linda Grinberg. Interview by John S. James. Grinberg L AIDS Treat News; 1999 Nov; (No 330):2-4. PubMed ID: 11367171 [TBL] [Abstract][Full Text] [Related]
2. New frontier of AIDS activism: international trade rules and global access to medicines. Interview by John S. James. Sawyer E AIDS Treat News; 1999 Apr; (No 317):1, 5-8. PubMed ID: 11366992 [TBL] [Abstract][Full Text] [Related]
3. AIDS practice issues today: interview with Paul Bellman, M.D. Interview by John S. James. Bellman P AIDS Treat News; 2000 Apr; (No 340):1-6. PubMed ID: 11367198 [TBL] [Abstract][Full Text] [Related]
4. Expanded and early access and patient assistance programs for other experimental drugs from their manufacturers. Crit Path AIDS Proj; 1998; (No 33):43-64. PubMed ID: 11366373 [TBL] [Abstract][Full Text] [Related]
5. 1592: protests on small access program. AIDS Treat News; 1997 Jun; (No 273):6-8. PubMed ID: 11364401 [TBL] [Abstract][Full Text] [Related]
6. A new approach for 'deep salvage' trials in advanced HIV infection. Lederman MM; Miller V; Weller I; Deeks SG AIDS; 2007 Jul; 21(12):1503-6. PubMed ID: 17630543 [TBL] [Abstract][Full Text] [Related]
7. FDA clarifies rules, allows combining antiretrovirals in clinical trials. Food and Drug Administration. AIDS Treat News; 1999 Nov; (No 331):5-6. PubMed ID: 11367127 [TBL] [Abstract][Full Text] [Related]
8. Antiretrovirals for the heavily experienced patient: hefty plans to holidays. Martinez LJ Res Initiat Treat Action; 1999 Oct; 5(4):5-8. PubMed ID: 11366942 [TBL] [Abstract][Full Text] [Related]
9. Children on losing end of access to new drugs. AIDS Alert; 1998 Jan; 13(1):10-2. PubMed ID: 11364862 [TBL] [Abstract][Full Text] [Related]
10. Treatment interruption; advanced HIV; new ideas: Dr. Cal Cohen interview on retrovirus conference (part 2 or 2). Interview by John S. James. Cohen C AIDS Treat News; 2003 Apr; (390):2-5. PubMed ID: 12739473 [TBL] [Abstract][Full Text] [Related]
11. [Development of antituberculous drugs: current status and future prospects]. Tomioka H; Namba K Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921 [TBL] [Abstract][Full Text] [Related]
12. FDA gives salvage therapy testing a push forward. Bass E AIDS Treat News; 2001 Mar; (362):3-7, 1. PubMed ID: 11569956 [TBL] [Abstract][Full Text] [Related]
13. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy. Van Vaerenbergh K Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503 [TBL] [Abstract][Full Text] [Related]
14. Protease inhibitors and beyond: interview with David Feigal, M.D. Interview by John S James. Feigal D AIDS Treat News; 1995 Mar; (no 219):1-6. PubMed ID: 11362331 [TBL] [Abstract][Full Text] [Related]
15. [Salvage therapy in HIV infection]. Salzberger B MMW Fortschr Med; 2004 Apr; 146 Spec No 1():52, 54-5, 57. PubMed ID: 15373050 [TBL] [Abstract][Full Text] [Related]
16. AIDS in the Third World: how to stop the HIV infection? De Clercq E Verh K Acad Geneeskd Belg; 2007; 69(2):65-80. PubMed ID: 17550059 [TBL] [Abstract][Full Text] [Related]
17. Virological and pharmacological factors associated with virological response to salvage therapy after an 8-week of treatment interruption in a context of very advanced HIV disease (GigHAART ANRS 097). Delaugerre C; Peytavin G; Dominguez S; Marcelin AG; Duvivier C; Gourlain K; Amellal B; Legrand M; Raffi F; Costagliola D; Katlama C; Calvez V J Med Virol; 2005 Nov; 77(3):345-50. PubMed ID: 16173015 [TBL] [Abstract][Full Text] [Related]
18. Challenge and co-operation: civil society activism for access to HIV treatment in Thailand. Ford N; Wilson D; Cawthorne P; Kumphitak A; Kasi-Sedapan S; Kaetkaew S; Teemanka S; Donmon B; Preuanbuapan C Trop Med Int Health; 2009 Mar; 14(3):258-66. PubMed ID: 19207173 [TBL] [Abstract][Full Text] [Related]
19. Removing US obstacles to AIDS healthcare. Pelosi N J Int Assoc Physicians AIDS Care; 1998 Feb; 4(2):32-4. PubMed ID: 11365087 [TBL] [Abstract][Full Text] [Related]
20. [Recommendations from the GESIDA/Spanish AIDS Plan regarding antiretroviral treatment in adults with human immunodeficiency virus infection (update February 2009)]. Panel de expertos de Gesida y Plan Nacional sobre el Sida Enferm Infecc Microbiol Clin; 2009 Apr; 27(4):222-35. PubMed ID: 19246124 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]